Brief: PolyPid Says Top-Line Results Of Phase 3 Shield II Trial Of D-PLEX(100) Expected In Mid-2024
04/10/2023 14:45
Oct 4 (Reuters) - PolyPid Ltd PYPD.O :
* POLYPID LTD - TOP-LINE RESULTS OF PHASE 3 SHIELD II TRIAL OF D-PLEX(100)
ARE
EXPECTED IN MID-2024
Further company coverage: PYPD.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Polypid
See all newsPolyPid Ltd reports results for the quarter ended June 30 - Earnings Summary
PolyPid Ltd expected to post a loss of 38 cents a share - Earnings Preview
Brief: Polypid Announces FDA Acceptance Of NDA With Priority Review For D-Plex₁₀₀
PolyPid, Azurity sign surgical site infection drug deal
Brief: Polypid Initiates D-Plex₁₀₀ NDA Submission To The FDA